Citadel Advisors’s TNF Pharmaceuticals, Inc. Common Stock TNFA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6936 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6797 |
|
|
2023
Q3 | – | Sell |
-9
| Closed | -$42K | – | 6633 |
|
|
2023
Q2 | $42K | Buy |
9
+7
| +350% | +$32.7K | ﹤0.01% | 5049 |
|
|
2023
Q1 | $8.37K | Sell |
2
-1
| -33% | -$4.18K | ﹤0.01% | 5553 |
|
|
2022
Q4 | $11.1K | Sell |
3
-11
| -79% | -$40.8K | ﹤0.01% | 5675 |
|
|
2022
Q3 | $113K | Buy |
14
+8
| +133% | +$64.6K | ﹤0.01% | 5070 |
|
|
2022
Q2 | $36K | Buy |
6
+2
| +50% | +$12K | ﹤0.01% | 5590 |
|
|
2022
Q1 | $60K | Sell |
4
-2
| -33% | -$30K | ﹤0.01% | 5848 |
|
|
2021
Q4 | $103K | Buy |
6
+1
| +20% | +$17.2K | ﹤0.01% | 5886 |
|
|
2021
Q3 | $112K | Sell |
5
-2
| -29% | -$44.8K | ﹤0.01% | 5799 |
|
|
2021
Q2 | $136K | Buy |
7
+3
| +75% | +$58.3K | ﹤0.01% | 5803 |
|
|
2021
Q1 | $81K | Sell |
4
-5
| -56% | -$101K | ﹤0.01% | 5939 |
|
|
2020
Q4 | $113K | Buy |
+9
| New | +$113K | ﹤0.01% | 4663 |
|
|
2019
Q4 | – | Hold |
0
| – | -$10K | – | 5210 |
|
|
2019
Q3 | – | Hold |
0
| – | -$10K | – | 4582 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 4566 |
|
|
2019
Q1 | – | Hold |
0
| – | -$25K | – | 5112 |
|
|
2018
Q4 | – | Hold |
0
| – | -$4K | – | 4219 |
|
|
2018
Q3 | – | Hold |
0
| – | -$115K | – | 4222 |
|
|
2018
Q2 | – | Hold |
0
| – | -$267K | – | 3808 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 3312 |
|
|
2017
Q2 | – | Hold |
0
| – | -$55K | – | 4268 |
|
|
2017
Q1 | – | Hold |
0
| – | -$20K | – | 3394 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 3455 |
|
|
2016
Q3 | – | Hold |
0
| – | -$34K | – | 4167 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 3111 |
|
|
2014
Q2 | – | Hold |
0
| – | -$59K | – | 3781 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3232 |
|